Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion

Blood

Volumn 100, Issue 12, 2002, Pages 3903-3907

  Akpek, Görgün ^a   Boitnott, John K ^a   Lee, Linda A ^a   Hallick, Jason P ^a   Torbenson, Michael ^a   Jacobsohn, David A ^a   Arai, Sally ^a   Anders, Viki ^a   Vogelsang, Georgia B ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLOSPORIN; METHOTREXATE; PREDNISONE; TACROLIMUS;

ACUTE HEPATITIS; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER DYSFUNCTION; LYMPHOCYTE DEPLETION; MALE; PRIORITY JOURNAL; VIRUS HEPATITIS;

EID: 0036893736     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-03-0857     Document Type: Article

References (24)

1. McDonald GB, Shulman HM, Sullivan KM, Spencer GD. Intestinal and hepatic complications of human bone marrow transplantation, I. Gastroenterology. 1986;90:460-477; 770-784.
2. Strasser SI, McDonald GB. Gastrointestinal and hepatic complications. In: Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic Cell Transplantation. Boston, MA: Blackwell Science; 1999: 627-658.
3. Yasmineh WG, Filipovich AH, Killeen AA. Serum 5′ nucleotidase and alkaline phosphatase-highly predictive liver function tests for the diagnosis of graft-versus-host disease in bone marrow transplant recipients. Transplantation. 1989;48:809-814.
4. Shulman HM, Sharma P, Amos D, Fenster LF, McDonald GB. A coded histological study of hepatic graft-versus-host disease after human transplantation. Hepatology. 1988;8:463-470.
5. Snover DC, Weisdorf SA, Ramsay AK, McGlave P, Kersey JH. Hepatic graft-versus-host disease: A study of the predictive value of liver biopsy in diagnosis. Hepatology. 1984;4:123-130.
6. Strasser SI, Shulman HM, Flowers ME, et al. Chronic graft-versus-host disease of the liver: Presentation as an acute hepatitis. Hepatology. 2000;32;1265-1271.
7. Fujii N, Takenaka K, Shinagawa K, et al. Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 2001;27:1007-1010.
8. Malik AH, Collins RH Jr, Saboorian MH, Lee WM. Chronic graft-versus-host disease after hematopoietic cell transplantation presenting as an acute hepatitis. Am J Gastroenterol. 2001;96:588-590.
9. Levine JE, Braun T, Penza SL, et al. Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation. J Clin Oncol. 2002;15;20:405-412.
10. de Lima M, Bonamino M, Vasconcelos Z, et al. Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: High remission rate among poor prognosis patients at the expense of graft-versus-host disease. Bone Marrow Transplant. 2001;27:73-78.
11. Alyea E, Weller E, Schlossman R, et al. T-celldepleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: Induction of graft-versusmyeloma effect. Blood. 2001;98:934-939.
12. Silberstein L, Davies A, Kelsey S, et al. Myositis, polyserositis with a large pericardial effusion and constrictive pericarditis as manifestations of chronic graft-versus-host disease after nonmyeloablative peripheral stem cell transplantation and subsequent donor lymphocyte infusion. Bone Marrow Transplant. 2001;27:231-233.
13. Beschorner WE, Pino J, Boitnott JK, Tutschka PJ, Santos GW. Pathology of the liver with bone marrow transplantation: Effects of busulfan, carmustine, acute graft-versus-host disease, and cytomegalovirus infection. Am J Pathol. 1980;99:369-385.
14. Martin PJ, Schoch G, Fisher L, et al. A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment. Blood. 1990;76: 1464-1472.
15. Martin PJ, Schoch G, Fisher L, et al. A retrospective analysis of therapy for acute graft-versus-host disease: Secondary treatment. Blood. 1991; 77:1821-1828.
16. Vinayek R, Demetris J, Rakela J. Liver disease in hematopoietic stem cell transplant recipients. In: Ball E, Lister J, Law P, eds. Hematopoietic Stem Cell Therapy. Philadelphia, PA: Churchill Livingstone; 2000;541-556.
17. Hill GR, Krenger W, Ferrara JL. The role of cytokines in acute graft-versus-host disease. Cytokines Cell Mol Ther. 1997;3:257-265.
18. Hill GR, Ferrara JL. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: Rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood. 2000;95:2754-2759.
19. Wasem C, Frutschi C, Arnold D, et al. Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease. J Immunol. 2001;167:2936-2941.
20. Hattori K, Hirano T, Miyajima H, et al. Differential effects of anti-Fas ligand and anti-tumor necrosis factor alpha antibodies on acute graft-versus-host disease pathologies. Blood. 1998;91:4051-4055.
21. Kuwahara H, Tani Y, Ogawa Y, Takaichi Y, Shiraishi A, Ohtsuki M. Therapeutic effect of novel anti-human Fas antibody HFE7a on graft-versushost disease model. Clin Immunol. 2001;99:340-346.
22. Murai M, Yoneyama H, Harada A, et al. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versushost disease. J Clin Invest. 1999;104:49-57.
23. + T cells to the liver, lung, and spleen during graft-versus-host disease. Blood. 2000;96: 2973-2980.
24. Li J, Helm K, Howell CD. Contributions of donor CD4 and CD8 cells to liver injury during murine graft-versus-host disease. Transplantation. 1996; 62:1621-1628.